Moelis (Moelis) 12-1 Month Momentum % : 35.89% (As of Apr. 28, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Moelis 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-28), Moelis's 12-1 Month Momentum % is 35.89%.

The industry rank for Moelis's 12-1 Month Momentum % or its related term are showing as below:

MC's 12-1 Month Momentum % is ranked better than
63.86% of 808 companies
in the Capital Markets industry
Industry Median: 15.575 vs MC: 35.89

Competitive Comparison of Moelis's 12-1 Month Momentum %

For the Capital Markets subindustry, Moelis's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moelis's 12-1 Month Momentum % Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Moelis's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Moelis's 12-1 Month Momentum % falls into.

Moelis (NYSE:MC) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %

( Price 1-month ago

Price 12-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moelis (NYSE:MC) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Moelis 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Moelis's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

Moelis (Moelis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Moelis & Co (NYSE:MC) » Definitions » 12-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

17M:Germany 17M:Germany

Address

399 Park Avenue, 4th Floor, New York, NY, USA, 10022

Website

https://www.moelis.com

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Executives

Kenneth Moelis	director, 10 percent owner, officer: Chairman and CEO	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Ciafone Katherine Pilcher	officer: Chief Operating Officer	399 PARK AVE, NEW YORK NY 10022
Kenneth Shropshire	director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10011
Elizabeth Crain	officer: Chief Operating Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Navid Mahmoodzadegan	director, officer: Managing Director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Osamu R. Watanabe	officer: General Counsel and Secretary	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Jeffrey Raich	director, officer: Managing Director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Christopher Callesano	officer: SVP & Principal Acct Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Laila Worrell	director	399 PARK AVENUE, NEW YORK NY 10022
Joseph Simon	officer: Chief Financial Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Yolonda C Richardson	director	399 PARK AVENUE, NEW YORK NY 10022
Leaman J Richard Iii	director, officer: Managing Partner	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
John A Allison	director	PO BOX 1250, WINSTON SALEM NC 27102-1250
Yvonne Greenstreet	director	PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, PARSIPPANY NJ 07054
Eric Cantor	director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022